EOD Primary Tumor
This input is used for staging
Notes
**Note 1:** **Bilateral involvement** * If both eyes are involved, code the information for the most extensively involved eye in this field. **Note 2:** **CLINICAL AND PATHOLOGICAL codes** * This schema has extension codes that are defined as “CLINICAL assessment only” or “PATHOLOGICAL assessment only” * **CLINICAL** assessment only codes (100, 125, 150, 200, 225, 325, 375, 425, 475, 525, 600, 650, 700) are used when there is a clinical work up only, including physical exam, imaging and biopsy (see **Note 3** for exception) * **PATHOLOGICAL** assessment only codes (175, 250, 275, 350, 400, 450, 500, 750) are used when there is a surgical resection of the primary site (enucleation)(see **Note 3** for exception) * Remaining codes (no designation of CLINICAL or PATHOLOGICAL only assessment) can be used based on clinical and/or pathological information **Note 3:** **Enucleation** * Pathological staging information from an enucleation always takes precedence over clinical staging * *Exception*: cases with neoadjuvant treatment where clinical disease is as extensive as or more extensive than disease at surgeryDefault
999NAACCR Item
NAACCR #772| Code | Description | SS2018 T |
|---|---|---|
| 100 | **CLINICAL assessment** Intraretinal tumor(s) with subretinal fluid - Equal to but not greater than 3 millimeter (mm) - AND Location not closer than 1.5 mm to optic disk or fovea | L |
| 125 | **CLINICAL assessment** Intraretinal tumor(s) with subretinal fluid - Greater than 3 millimeter (mm) - AND Location closer than 1.5 mm from disc or fovea | L |
| 150 | **CLINICAL assessment** Intraretinal tumor(s) with subretinal fluid ≤5 mm from the base of any tumor Tumor confined to retina, NOS Localized, NOS | L |
| 175 | **PATHOLOGICAL assessment only** Intraocular tumor(s) WITHOUT any - Local invasion - Focal choroidal invasion - Pre- or intralaminar involvement of the optic nerve head Tumor confined to retina, NOS Localized, NOS | L |
| 200 | **CLINICAL assessment only** Intraocular tumor(s) WITH - Subretinal fluid greater than 5 mm [0.5 cm] from base of tumor - WITH or WITHOUT retinal detachment | L |
| 225 | **CLINICAL assessment only** Intraocular tumor(s) WITH - Vitreous seeding and/or subretinal seeding - WITH or WITHOUT retinal detachment | L |
| 250 | **PATHOLOGICAL assessment only** Intraocular tumor(s) WITH local invasion - Concomitant focal choroidal invasion - AND pre- or intralaminar involvement of optic nerve head | L |
| 275 | **PATHOLOGICAL assessment only** Intraocular tumor(s) WITH local invasion Stromal invasion iris - AND/OR trabecular meshwork - AND/OR Schlemm's canal | L |
| 300 | Intraocular tumor(s) WITH local invasion, NOS Intraocular tumor(s) with retinal detachment, vitreous seeding, or subretinal seeding, NOS | L |
| 325 | **CLINICAL assessment only** Advanced intraocular tumor(s) WITH - Phthisis or pre-phthisis bulbi | L |
| 350 | **PATHOLOGICAL assessment only** Intraocular tumor(s) WITH significant local invasion - Massive choroidal invasion (greater than 3 mm [0.3 cm] in largest diameter) - OR multiple foci or focal choroidal involvement (greater than 3 mm) - OR full-thickness choroidal involvement | L |
| 375 | **CLINICAL assessment only** Advanced intraocular tumor(s) WITH invasion of - Anterior chamber - Choroid - Ciliary body - Iris - Lens - Pars plana - Zonules | L |
| 400 | **PATHOLOGICAL assessment only** Intraocular tumor(s) WITH significant local invasion - Retrolaminar invasion of optic nerve head - NOT involving transected end of optic nerve | L |
| 425 | **CLINICAL assessment only** Advanced intraocular tumor(s) WITH - Raised intraocular pressure with neovascularization - AND/OR buphthalmos | L |
| 450 | **PATHOLOGICAL assessment only** Intraocular tumor(s) WITH significant local invasion - Any partial-thickness involvement of sclera within inner two thirds | L |
| 475 | **CLINICAL assessment only** Advanced intraocular tumor(s) WITH - Hyphema AND/OR massive vitreous hemorrhage | L |
| 500 | **PATHOLOGICAL assessment only** Advanced intraocular tumor(s) WITH - Full-thickness invasion into outer third of sclera - AND/OR invasion into or around emissary channels | L |
| 525 | **CLINICAL assessment only** Advanced intraocular tumor(s) WITH - Aseptic orbital cellulitis | L |
| 550 | Advanced intraocular tumor(s) WITH significant local invasion | L |
| 600 | **CLINICAL assessment only** Extraocular tumor(s) involving orbit - Radiologic evidence of retrobulbar optic nerve involvement - OR thickening of optic nerve and/or orbital tissues | RE |
| 650 | **CLINICAL assessment only** Extraocular tumor(s) involving orbit, including optic nerve - WITH proptosis AND/OR an orbital mass | RE |
| 700 | **CLINICAL assessment only** Extraocular tumor(s) involving orbit, including optic nerve, NOS | RE |
| 750 | **PATHOLOGICAL assessment only** Evidence of extraocular tumor - Tumor at transected end of optic nerve - Tumor in the meningeal spaces around optic nerve Full-thickness invasion of sclera WITH invasion of - Adjacent adipose tissue - Bone - Conjunctiva - Episclera - Extraocular muscle - Eyelids | RE |
| 800 | No evidence of primary tumor | U |
| 999 | Unknown; extension not stated Primary tumor cannot be assessed Not documented in medical record Death Certificate Only | U |